Medroxyprogesterone Compared With Venlafaxine in Treating Hot Flashes in Women

PHASE3CompletedINTERVENTIONAL
Enrollment

227

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

February 28, 2006

Study Completion Date

September 30, 2006

Conditions
Hot Flashes
Interventions
DRUG

medroxyprogesterone

DRUG

venlafaxine

Trial Locations (22)

29303

CCOP - Upstate Carolina, Spartanburg

32224

Mayo Clinic - Jacksonville, Jacksonville

48106

CCOP - Michigan Cancer Research Consortium, Ann Arbor

54301

CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay

55805

CCOP - Duluth, Duluth

55905

Mayo Clinic Cancer Center, Rochester

56303

Coborn Cancer Center, Saint Cloud

57104

CCOP - Sioux Community Cancer Consortium, Sioux Falls

57709

Rapid City Regional Hospital, Rapid City

61602

CCOP - Illinois Oncology Research Association, Peoria

61801

CCOP - Carle Cancer Center, Urbana

68106

CCOP - Missouri Valley Cancer Consortium, Omaha

74136

CCOP - Oklahoma, Tulsa

96813

MBCCOP - Hawaii, Honolulu

85259-5404

CCOP - Mayo Clinic Scottsdale Oncology Program, Scottsdale

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

50309-1016

CCOP - Iowa Oncology Research Association, Des Moines

51101-1733

Siouxland Hematology-Oncology, Sioux City

67214-3882

CCOP - Wichita, Wichita

58501-5505

Medcenter One Health System, Bismarck

43623-3456

CCOP - Toledo Community Hospital, Toledo

15212-4772

Allegheny General Hospital, Pittsburgh

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00030914 - Medroxyprogesterone Compared With Venlafaxine in Treating Hot Flashes in Women | Biotech Hunter | Biotech Hunter